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Conclusions: RVP-induced dyssynchronous heart failure could aggravate ﬁbrosis due
to regional heterogeneity of mechanical stress, and it could be partly attenuated by
BiVP, in which mechanical stress-induced EndMT might play pivotal role through
integrin b1 pathway.
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Lipoxin A4 inhibits lipid uptake and oxLDL-induced apoptosis in macrophages
with suppressed biosynthesis in atherosclerotic arteries
Mai Jingting, Yangxin Chen, Qiong Qiu, Woliang Yuan, Jingfeng Wang,
Jingfeng Wang
Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Objectives: To test whether anti-inﬂammatory lipid mediator Lipoxin A4 (LXA4) can
inhibit foam cell formation and macrophages apoptosis, and determine the circulating
and local LXA4 biosynthesis status in atherosclerosis.
Methods: Macrophages apoptosis was evaluated by TUNEL and Annexin V. Mito-
chondrial membrane potential was assayed by JC-1 Assay Kit. Serum and tissue levels
of LXA4 were assayed by ELISA kits.
Results: LXA4 signiﬁcantly suppressed cholesterol uptake genes CD36 and SR-A
expression in a dose-dependent manner in THP-1 macrophages and human monocyte
derived macrophages (from coronary artery disease patients), which could be abol-
ished by LXA4 receptor antagonist BOC-2. Furthermore, LXA4 could inhibit oxLDL-
induced CD36 upregulation. The uptake of Dil-oxLDL and Dil-acLDL as well as
foam cell formation were inhibited under LXA4 stimulation. It was observed that
LXA4 could reduce oxLDL-induced apoptosis in macrophages through inhibiting
caspase-3 activation and restoring mitochondrial membrane potential. Moreover,
cotreatment with LXA4 signiﬁcantly inhibited JNK pathway activated by ox-LDL.
Circulating levels in stable coronary artery disease patients were much higher than that
in nonobstructive patients. Local LXA4 levels were lower but IFN-g levels were
higher in rabbit atherosclerotic vessel walls. In addition, in vitro experiment found that
IFN-g could suppress LXA4 production in activated macrophages and foam cells.
Conclusions: LXA4 could inhibit foam cell formation and oxLDL-induced apoptosis
in macrophages. Increase of circulating LXA4 and decrease of local LXA4 were
observed in atherosclerosis, which indicated that locally but not systematically inad-
equate production of resolution mediators might be the key reason in maintaining
nonresolving inﬂammation in atherosclerosis.
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Objectives: We thought to evaluate the possible association between several poly-
morphisms in PPARg gene and metabolic syndrome (MS), using two approaches, a
case-control study and a family-based study.
Methods: Subjects and Measurements Subjects of 605 participated in the study. Case
patients (of MS) of 94 and 131 control subjects participated in a case-control study.
Family-based study included 149 probands and 231 siblings (from 90 families). BMI,
fasting blood sugar (FBS), TC, TG, and HDL-c levels were measured. Genotyping We
detected 7 polymorphisms of PPARg gene, including two prevalence polymorphisms
Pro12Ala (rs1801282) and C161T (rs3856806) and other ﬁve single-nucleotide
polymorphisms (SNP): -553T/C (from the beginning of exon A2), -267T/A (from the
beginning of exon A2), -628G/A (from the beginning of exon 1), rs7650213G/T, and
rs13306747C/G, using a method of RFLP-PCR. Statistical Analysis Differences of
quantitative traits were compared with one way ANOVA. SPSS software 13.0 was
used. Pairwise linkage disequilibrium (LD) expressed in terms of D’ and r2 parameters
and haplotype frequencies were estimated using the THESIAS program. A P val-
ue<0.05 was considered signiﬁcant. The transmission of alleles to affected subjects
with MS or unaffected subjects was analyzed using the transmission disequilibrium
test (TDT) by TRANSMIT software. The proportion T of “overtransmitted” or “high-
risk” alleles from informative parents was estimated by counting informative
transmissions.
Results: Case-Control Study: No signiﬁcant differences could be observed between the
cases and controls of seven polymorphisms (P>0.05). Six common haplotypes were
analyzed. The corresponding ORs of the MS for carriers of the rare allele versus ho-
mozygotes for the common allele of the seven polymorphisms varied from 0.26 to 0.74
(all P>0.05). A lower risk of the MS was observed of haplotype TTCGGCT versus
common homozygote haplotype TTCGGCC. The TTCGGCT haplotype was lower
frequent in MS patients than in control subjects. But it was not signiﬁcant (P¼0.086) .In
pairwise linkage disequilibrium analysis, the polymorphism rs1801282 (all D’>0.5) and
rs7650213 (all D’>0.7) were in linkage disequilibrium with other six polymorphisms.
Family-based Study: In TDT analysis of the pedigree of MS probands of seven
polymorphisms, the patients were more likely to inherit the homozygotes of two poly-
morphisms, C allele (Pro) of rs1801282 and the C allele of rs3856806 (P<0.05). Similar
results were not found in other ﬁve polymorphisms. There was a signiﬁcant lower
transmission of the haplotypes CTGGTCC (P<0.05) in haplotypes analysis of seven
polymorphisms. Other haplotypes were not found overtransmitted or lower transmitted.
Conclusions: In case-control study, seven polymorphisms and their haplotypes of
PPARg are not associated with MS. While in family-based study, two polymorphisms
of PPARg gene, rs1801282 (Pro12Ala) and the rs3856806 (C161T) decrease the risk
of the MS. And the haplotype CTGGTCC of seven polymorphisms can decrease theJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Brisk of MS in MS families. Therefore, PPARg polymorphisms are associated with MS
especially in families.
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Urine may be a preferred source to generate induced pluripotent stem cell-
derived cardiomyocytes for cardiac regenerative medicine
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Objectives: To test proof-of-principle if human iPSCs can be established by the
transduction of transcription factors (Oc-t4, Sox-2, Klf-4, and c-Myc) into human
adult urine cells and observe whether these iPSCs can be differentiated into
cardiomyocytes.
Methods: We used directed differentiation protocols to derive cardiomyocytes using
serum-free, chemically-deﬁned media supplemented with BMP4, Activin A, bFGF,
VEGF and DKK-1 in stage speciﬁc manner as previously described.
Results: In our study, positive results were obtained from the immunoﬂuorescence
staining of Oct-4, SSEA-4, Nanog, TRA-1-60 and alkaline phosphatase staining of our
putative human iPS cells, which indicated that the reprogrammed human urine cells
were expressing these typical embryonic stem cell (ESC) markers. The putative iPSCs
were ESC-like and showed excellent differentiation potential into lineages derived
from the primary three embryonic germ layers both in vitro and in vivo. Importantly,
after cardiac differentiation from the above iPSCs, spontaneously beating outgrowths
appeared approximately 14 to 21 days in embryoid bodies. Stable action potential
(AP) recorded from spontaneously beating clusters and expression of the cardiac
speciﬁc markers (troponin-T, a- actinin, MLC-2v, MLC-2a and HCN4) clearly
conﬁrmed the differentiation of iPSCs into cardiomyocyte in our study.
Conclusions: With these ﬁndings, we hypothesize that urine may be a preferred
source in a totally noninvasive manner for generating iPS cell-derived cardiomyocytes
for cardiac regenerative medicine.
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The progress of cardiac stem cell study
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Objectives: At present the treatment of heart disease have much difﬁculty. The main
causes are due to that drug therapy and percutanenus coronary intervention (PCI) or
coronary artery bypass grafting (CABG) could not increase the number of car-
diomyocytes, so the cardiac function does not enhanced much better. According to this,
the numbers of cardiomyocytes is the key. In a single day the heart failure happens, both
drug therapy and PCI can also not increase the number of cardiomyocytes and the heart
function. With the development about stem cell researches, many studies have testiﬁed
that transplanting of cardiac stem cells can enhanced the ejection fraction (HF) and
cardiac function. The stem cell treatment outstandingly prolongs life-span and improves
the prognosis of the patient suffering from heart failure
Methods: The paper summarized the recent results and clariﬁed the kinds of cardiac
stem cells. The paper overviews the method inducing stem cells into cardiomyocytes.
It also shows the clinic works having been made about cardiac stem cells.
Results: All clinic studies have a signiﬁcative conclusion increasing ejection fraction
of heart. Through that it discusses the modifying technology regulating stem cells.
Conclusions: At last the article reveals the biological organ future of clinic
transplantation.
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MicroRNA-19b Acts as Potential Anti-thrombotic Protector in Coronary Artery
Disease by Targeting Tissue Factor
Li Sufang, Chen Hong
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Objectives: Thrombosis plays a critical role in the pathogenesis of acute coronary
events. Microparticles (MPs) are the major carrier of miRNAs in circulation. Tissue
factor (TF), the initiator of extrinsic coagulation cascade, may be regulated by
microRNAs (miRNAs). The aim of this study was to determine the potential role of
miRNAs in regulating gene experession involved in thrombosis in coronary artery
disease (CAD) .
Methods: MiRNA expression proﬁles in the plasma of patients with typical unstable
angina (UA) and angiographically documented CAD compared with individuals with
clinical suspicion of CAD but negative angiography were analyzed using Taqman low-
density miRNA array. Levels of selected ﬁve miRNAs in plasma and plasma MPs were
validated by real-time PCR. The characteristic of endothelial microparticles (EMPs)
from plasma were analyzed by ﬂow cytometry. In endothelial cells (ECs, EA.hy926
cells) and MPs releasd by ECs incubated with TNF-a, the levels of miR-19b were
examined by real-time PCR. The target gene of miR-19b associated with thrombosis
were pridicted by TargetScan and miRanda. Luciferase reporter assays were performed
to conﬁrm the binding of miR-19b to TF mRNA. TF expression induced by TNF-a in
ECs was tested by real-time PCR. ECs were transfected with miR-19b mimic and the
expression of TF were analyzed by real-time PCR and western blotting. Procoagulant
activity of TF was analysed in miR-19b overexpressed ECs.
Results: Amomg 36 differential expressed miRNAs, miR-19b was the most obviously
upregulated one. In UA patients, miR-19b level was upregulated in plasmaasic and Translational Medicine C63
